Senior Director, Global HEOR Marketed Product Scientist

argenx
•$264,000 - $363,000•Remote

About The Position

The Senior Director, HEOR Marketed Products Scientist is accountable for the HEOR value-evidence strategy across related conditions in a branch of medicine within argenx’s marketed product portfolio, currently rheumatology, with a growing portfolio expected. The role works with Pipeline HEOR to inform readiness for future rheumatology indications and launches, sets and defends the multi-year marketed-products HEOR strategy and budget, and represents Global HEOR in global brand, launch, and value-governance forums. Working closely with Pipeline HEOR, Real World Evidence, Medical Affairs & Evidence Generation, and Market Access, the Senior Director ensures a coherent evidence continuum from late-stage development through launch and lifecycle expansion. The role shapes economic models, HTA and payer value evidence, patient-centred and burden-of-illness evidence, and evidence dissemination through congresses, peer-reviewed publications, and payer and HTA interactions. The successful candidate operates with a high degree of autonomy and enterprise judgement and is accountable for the quality, impact, budget, and timelines of a developing portfolio of HEOR programs.

Requirements

  • PhD, MD, PharmD, or a relevant master’s degree in health economics, outcomes research, epidemiology, public health, pharmacy, or a related discipline.
  • At least 10 years of pharmaceutical or biotech industry experience, with strong knowledge of drug development, commercialization, and regulatory and compliance requirements.
  • At least 8 years of HEOR experience, including depth in health economic modelling, evidence synthesis, epidemiology, quality-of-life and patient-reported outcomes, real-world evidence, and communicating HEOR results to decision makers.
  • Demonstrated experience leading HEOR strategy for marketed products, including multi-indication portfolios, and accountability for multi-million-dollar budgets.
  • Launch experience with orphan or specialty medicines, with a strong understanding of US payer and market access dynamics and HTA requirements in ex-US markets.
  • Ability to lead cross-functional teams and influence senior stakeholders without formal authority.
  • Strong publication record and recognized external presence in the HEOR community.
  • Excellent written and verbal communication and interpersonal skills; fluent English.
  • Ability to travel up to 20% of the time as needed.

Nice To Haves

  • Experience in rare disease, immunology, or rheumatology is strongly preferred.

Responsibilities

  • Own the multi-year HEOR evidence-generation strategy for the marketed portfolio, aligned with brand, medical, market access, and pricing strategies, and demonstrate product value to payers, HTA bodies, providers, and patients globally.
  • Set and defend the marketed-products HEOR investment case and budget with senior leadership; prioritize across indications, geographies, and methods; and deliver the agreed plan within budget and timelines.
  • Represent HEOR in global brand, launch-readiness, value, and evidence-governance forums, providing decision-ready recommendations on value evidence, pricing-relevant evidence, and HTA risk mitigation.
  • Lead, coach, and develop HEOR scientists and matrix contributors; set scientific standards; review protocols and deliverables; and build functional capability.
  • Partner with Pipeline HEOR on evidence responsibility as indications transition through Phase 3 to launch, and bring marketed-product and market-facing insights into development-stage evidence plans.
  • Partner with Real World Evidence colleagues to align registry, claims, chart-review, and prospective observational programs with HEOR and HTA evidence needs and avoid duplication.
  • Direct HEOR research, including cost-effectiveness and budget-impact models, indirect treatment comparisons, systematic reviews, burden-of-illness and cost-of-illness studies, humanistic and productivity outcomes, and preference research, from concept through execution, publication, and use in decision-maker interactions.
  • Oversee the marketed-products HEOR publication and dissemination strategy with Scientific Communications, including congress presentations, peer-reviewed publications, and proactive and reactive communication tools.
  • Ensure HEOR evidence and economic models are fit for global and regional HTA and payer submissions, and support affiliates with adaptation, local validation, and responses to HTA questions.
  • Select and govern external research collaborators, academic centres, and vendors, with accountability for scientific quality, contracting, compliance, and value for money.
  • Represent argenx with payers, HTA bodies, key opinion leaders, professional societies, and patient organizations, in partnership with Market Access, Medical Affairs & Evidence Generation, and Patient Advocacy.
  • As requested, develop and deliver HEOR presentations to formulary committees, HTA bodies, and other decision makers, and respond to their questions and challenges.
  • Build relationships with HEOR thought leaders and academics to shape methodological advances and research agendas relevant to rare autoimmune disease, and establish external recognition as an argenx HEOR expert.
  • Translate complex value evidence into clear, compelling narratives for internal and external audiences, including senior leadership.
  • Contribute to Global HEOR functional strategy, ways of working, standards, and vendor and platform decisions beyond the immediate portfolio.

Benefits

  • Eligible to participate in short-term and long-term incentive programs, subject to plan terms and applicable policies.
  • Comprehensive benefits package, including retirement savings plans and health benefits.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service